Gcn5 is required for PU.1-dependent IL-9 induction in Th9 cells

Journal of Immunology

Volumn 189, Issue 6, 2012, Pages 3026-3033

  Goswami, Ritobrata ^a   Kaplan, Mark H ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE ACETYLTRANSFERASE GCN5; HISTONE ACETYLTRANSFERASE PCAF; HISTONE DEACETYLASE; INTERLEUKIN 10; INTERLEUKIN 21; INTERLEUKIN 9; TRANSCRIPTION FACTOR PU 1;

ANIMAL CELL; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME INHIBITION; FEMALE; GENE; GENE LOCUS; HELPER CELL; HISTONE ACETYLATION; IL9 GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE SUBPOPULATION; TH9 CELL; TRANSCRIPTION REGULATION;

ACETYLATION; ANIMALS; CELLS, CULTURED; FEMALE; HISTONE ACETYLTRANSFERASES; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; INTERLEUKIN-9; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; P300-CBP TRANSCRIPTION FACTORS; PROTO-ONCOGENE PROTEINS; T-LYMPHOCYTES, HELPER-INDUCER; TRANS-ACTIVATORS;

EID: 84866167335     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201496     Document Type: Article

References (49)

1. Zhu, J., H. Yamane, and W. E. Paul. 2010. Differentiation of effector CD4 T cell populations (*). Annu. Rev. Immunol. 28: 445-489.
2. Dardalhon, V., A. Awasthi, H. Kwon, G. Galileos, W. Gao, R. A. Sobel, M. Mitsdoerffer, T. B. Strom, W. Elyaman, I. C. Ho, et al. 2008. IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells. Nat. Immunol. 9: 1347-1355.
3. Veldhoen, M., C. Uyttenhove, J. van Snick, H. Helmby, A. Westendorf, J. Buer, B. Martin, C. Wilhelm, and B. Stockinger. 2008. Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat. Immunol. 9: 1341-1346.
4. Jabeen, R., and M. H. Kaplan. 2012. The symphony of the ninth: the development and function of Th9 cells. Curr. Opin. Immunol. 24: 303-307.
5. Chang, H. C., S. Sehra, R. Goswami, W. Yao, Q. Yu, G. L. Stritesky, R. Jabeen, C. McKinley, A. N. Ahyi, L. Han, et al. 2010. The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat. Immunol. 11: 527-534.
6. Goswami, R., R. Jabeen, R. Yagi, D. Pham, J. Zhu, S. Goenka, and M. H. Kaplan. 2012. STAT6-dependent regulation of Th9 development. J. Immunol. 188: 968-975.
7. Staudt, V., E. Bothur, M. Klein, K. Lingnau, S. Reuter, N. Grebe, B. Gerlitzki, M. Hoffmann, A. Ulges, C. Taube, et al. 2010. Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity 33: 192-202.
8. Klemsz, M. J., and R. A. Maki. 1996. Activation of transcription by PU.1 requires both acidic and glutamine domains. Mol. Cell. Biol. 16: 390-397. (Pubitemid 126506986)
9. Fisher, R. C., M. C. Olson, J. M. Pongubala, J. M. Perkel, M. L. Atchison, E. W. Scott, and M. C. Simon. 1998. Normal myeloid development requires both the glutamine-rich transactivation domain and the PEST region of transcription factor PU.1 but not the potent acidic transactivation domain. Mol. Cell. Biol. 18: 4347-4357. (Pubitemid 28287957)
10. Ahyi, A. N., H. C. Chang, A. L. Dent, S. L. Nutt, and M. H. Kaplan. 2009. IFN regulatory factor 4 regulates the expression of a subset of Th2 cytokines. J. Immunol. 183: 1598-1606.
11. Chang, H. C., S. Zhang, V. T. Thieu, R. B. Slee, H. A. Bruns, R. N. Laribee, M. J. Klemsz, and M. H. Kaplan. 2005. PU.1 expression delineates heterogeneity in primary Th2 cells. Immunity 22: 693-703. (Pubitemid 40814500)
12. Chang, H. C., L. Han, R. Jabeen, S. Carotta, S. L. Nutt, and M. H. Kaplan. 2009. PU.1 regulates TCR expression by modulating GATA-3 activity. J. Immunol. 183: 4887-4894.
13. Strahl, B. D., and C. D. Allis. 2000. The language of covalent histone modifications. Nature 403: 41-45. (Pubitemid 30038513)
14. Cress, W. D., and E. Seto. 2000. Histone deacetylases, transcriptional control, and cancer. J. Cell. Physiol. 184: 1-16. (Pubitemid 30349623)
15. Li, J., Q. Lin, W. Wang, P. Wade, and J. Wong. 2002. Specific targeting and constitutive association of histone deacetylase complexes during transcriptional repression. Genes Dev. 16: 687-692. (Pubitemid 34274038)
16. Utley, R. T., K. Ikeda, P. A. Grant, J. Côté, D. J. Steger, A. Eberharter, S. John, and J. L. Workman. 1998. Transcriptional activators direct histone acetyltransferase complexes to nucleosomes. Nature 394: 498-502. (Pubitemid 28373963)
17. Luo, R. X., and D. C. Dean. 1999. Chromatin remodeling and transcriptional regulation. J. Natl. Cancer Inst. 91: 1288-1294. (Pubitemid 29387570)
18. Van Lint, C., S. Emiliani, and E. Verdin. 1996. The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. Gene Expr. 5: 245-253.
19. Kouzarides, T. 2000. Acetylation: a regulatory modification to rival phosphorylation? EMBO J. 19: 1176-1179. (Pubitemid 30151013)
20. Lee, K. K., and J. L. Workman. 2007. Histone acetyltransferase complexes: one size doesn't fit all. Nat. Rev. Mol. Cell Biol. 8: 284-295. (Pubitemid 46474661)
21. Carotta, S., L. Wu, and S. L. Nutt. 2010. Surprising new roles for PU.1 in the adaptive immune response. Immunol. Rev. 238: 63-75.
22. Mak, K. S., A. P. Funnell, R. C. Pearson, and M. Crossley. 2011. PU.1 and Haematopoietic Cell Fate: Dosage Matters. Int. J. Cell Biol. 2011: 808524.
23. Bai, Y., L. Srinivasan, L. Perkins, and M. L. Atchison. 2005. Protein acetylation regulates both PU.1 transactivation and Ig kappa 39 enhancer activity. J. Immunol. 175: 5160-5169. (Pubitemid 41456400)
24. Dakic, A., D. Metcalf, L. Di Rago, S. Mifsud, L. Wu, and S. L. Nutt. 2005. PU.1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis. J. Exp. Med. 201: 1487-1502. (Pubitemid 40664092)
25. Perumal, N. B., and M. H. Kaplan. 2011. Regulating Il9 transcription in T helper cells. Trends Immunol. 32: 146-150.
26. Kaplan, M. H., N. L. Glosson, G. L. Stritesky, N. Yeh, J. Kinzfogl, S. L. Rohrabaugh, R. Goswami, D. Pham, D. E. Levy, R. R. Brutkiewicz, et al. 2011. STAT3-dependent IL-21 production from T helper cells regulates hematopoietic progenitor cell homeostasis. Blood 117: 6198-6201.
27. Jash, A., A. Sahoo, G. C. Kim, C. S. Chae, J. S. Hwang, J. E. Kim, and S. H. Im. 2012. Nuclear factor of activated T cells 1 (NFAT1)-induced permissive chromatin modification facilitates nuclear factor-κB (NF-κB)- mediated interleukin-9 (IL-9) transactivation. J. Biol. Chem. 287: 15445-15457.
28. Xu, W., D. G. Edmondson, Y. A. Evrard, M. Wakamiya, R. R. Behringer, and S. Y. Roth. 2000. Loss of Gcn5l2 leads to increased apoptosis and mesodermal defects during mouse development. Nat. Genet. 26: 229-232.
29. Kuo, M. H., J. E. Brownell, R. E. Sobel, T. A. Ranalli, R. G. Cook, D. G. Edmondson, S. Y. Roth, and C. D. Allis. 1996. Transcription-linked acetylation by Gcn5p of histones H3 and H4 at specific lysines. Nature 383: 269-272.
30. Zhang, W., J. R. Bone, D. G. Edmondson, B. M. Turner, and S. Y. Roth. 1998. Essential and redundant functions of histone acetylation revealed by mutation of target lysines and loss of the Gcn5p acetyltransferase. EMBO J. 17: 3155-3167. (Pubitemid 28254387)
31. Kouzarides, T. 2007. Chromatin modifications and their function. Cell 128: 693-705. (Pubitemid 46273577)
32. Hagemeier, C., A. J. Bannister, A. Cook, and T. Kouzarides. 1993. The activation domain of transcription factor PU.1 binds the retinoblastoma (RB) protein and the transcription factor TFIID in vitro: RB shows sequence similarity to TFIID and TFIIB. Proc. Natl. Acad. Sci. USA 90: 1580-1584. (Pubitemid 23058217)
33. Kominato, Y., D. Galson, W. R. Waterman, A. C. Webb, and P. E. Auron. 1995. Monocyte expression of the human prointerleukin 1 beta gene (IL1B) is dependent on promoter sequences which bind the hematopoietic transcription factor Spi-1/PU.1. Mol. Cell. Biol. 15: 58-68. (Pubitemid 24379901)
34. Shin, M. K., and M. E. Koshland. 1993. Ets-related protein PU.1 regulates expression of the immunoglobulin J-chain gene through a novel Ets-binding element. Genes Dev. 7: 2006-2015. (Pubitemid 23312952)
35. Rogers, S., R. Wells, and M. Rechsteiner. 1986. Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. Science 234: 364-368. (Pubitemid 17181385)
36. Rechsteiner, M., and S. W. Rogers. 1996. PEST sequences and regulation by proteolysis. Trends Biochem. Sci. 21: 267-271. (Pubitemid 26228278)
37. Erman, B., and R. Sen. 1996. Context dependent transactivation domains activate the immunoglobulin mu heavy chain gene enhancer. EMBO J. 15: 4665-4675. (Pubitemid 26294584)
38. Nishiyama, C., M. Nishiyama, T. Ito, S. Masaki, N. Masuoka, H. Yamane, T. Kitamura, H. Ogawa, and K. Okumura. 2004. Functional analysis of PU.1 domains in monocyte-specific gene regulation. FEBS Lett. 561: 63-68. (Pubitemid 38324608)
39. Karim, F. D., L. D. Urness, C. S. Thummel, M. J. Klemsz, S. R. McKercher, A. Celada, C. Van Beveren, R. A. Maki, C. V. Gunther, J. A. Nye, et al. 1990. The ETS-domain: a new DNA-binding motif that recognizes a purine-rich core DNA sequence. Genes Dev. 4: 1451-1453. (Pubitemid 20310065)
40. Klemsz, M. J., S. R. McKercher, A. Celada, C. Van Beveren, and R. A. Maki. 1990. The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene. Cell 61: 113-124.
41. Nagulapalli, S., J. M. Pongubala, and M. L. Atchison. 1995. Multiple proteins physically interact with PU.1. Transcriptional synergy with NF-IL6 beta (C/EBP delta, CRP3). J. Immunol. 155: 4330-4338.
42. Hlubek, F., C. Löhberg, J. Meiler, A. Jung, T. Kirchner, and T. Brabletz. 2001. Tip60 is a cell-type-specific transcriptional regulator. J. Biochem. 129: 635-641. (Pubitemid 32299287)
43. Katsumoto, T., Y. Aikawa, A. Iwama, S. Ueda, H. Ichikawa, T. Ochiya, and I. Kitabayashi. 2006. MOZ is essential for maintenance of hematopoietic stem cells. Genes Dev. 20: 1321-1330. (Pubitemid 43727592)
44. Stopka, T., D. F. Amanatullah, M. Papetti, and A. I. Skoultchi. 2005. PU.1 inhibits the erythroid program by binding to GATA-1 on DNA and creating a repressive chromatin structure. EMBO J. 24: 3712-3723. (Pubitemid 41581688)
45. Shakespear, M. R., M. A. Halili, K. M. Irvine, D. P. Fairlie, and M. J. Sweet. 2011. Histone deacetylases as regulators of inflammation and immunity. Trends Immunol. 32: 335-343.
46. Grausenburger, R., I. Bilic, N. Boucheron, G. Zupkovitz, L. El-Housseiny, R. Tschismarov, Y. Zhang, M. Rembold, M. Gaisberger, A. Hartl, et al. 2010. Conditional deletion of histone deacetylase 1 in T cells leads to enhanced airway inflammation and increased Th2 cytokine production. J. Immunol. 185: 3489-3497.
47. Laribee, R. N., and M. J. Klemsz. 2001. Loss of PU.1 expression following inhibition of histone deacetylases. J. Immunol. 167: 5160-5166. (Pubitemid 33009752)
48. Ramming, A., D. Druzd, J. Leipe, H. Schulze-Koops, and A. Skapenko. 2012. Maturation-related histone modifications in the PU.1 promoter regulate Th9-cell development. Blood 119: 4665-4674.
49. Sansó, M., I. Vargas-Pérez, L. Quintales, F. Antequera, J. Ayté, and E. Hidalgo. 2011. Gcn5 facilitates Pol II progression, rather than recruitment to nucleosome-depleted stress promoters, in Schizosaccharomyces pombe. Nucleic Acids Res. 39: 6369-6379.